Company Filing History:
5 out of 2,893 
2 out of 263 
1 out of 1,552 
Years Active: 2019-2024
Title: The Innovative Contributions of David Pepin
Introduction
David Pepin is a notable inventor based in Somerville, MA, who has made significant contributions to the field of reproductive health. With a total of five patents to his name, Pepin's work focuses on the use of Mullerian inhibiting substance (MIS) proteins for various applications, including contraception and ovarian preservation.
Latest Patents
One of Pepin's latest patents involves the use of MIS proteins for contraception and ovarian reserve preservation. This invention provides a method of contraception by administering a composition containing MIS to a female subject. The MIS can be produced endogenously in the subject through a vector that encodes a recombinant MIS protein. In certain embodiments, this method offers a permanent solution that requires only a single administration of the composition. Another aspect of this invention relates to preserving ovarian reserve by administering a composition comprising MIS or an inducible vector encoding a recombinant MIS protein.
Additionally, Pepin has developed methods for ovarian and uterine oncoprotection, as well as for treating polycystic ovary syndrome (PCOS). These methods involve administering a composition containing MIS to protect ovarian function during cytotoxic treatments, such as chemotherapy, and to induce an arrest of folliculogenesis to preserve fertility.
Career Highlights
Throughout his career, David Pepin has worked with esteemed organizations, including The General Hospital Corporation and Massachusetts Eye and Ear Infirmary. His innovative research has contributed to advancements in reproductive health and fertility preservation.
Collaborations
Pepin has collaborated with notable colleagues, including Patricia K. Donahoe and Demetrios Vavvas, further enhancing the impact of his work in the field.
Conclusion
David Pepin's contributions to the field of reproductive health through his innovative patents demonstrate his commitment to advancing medical science. His work on MIS proteins has the potential to significantly improve contraception methods and fertility preservation techniques.